BrightSpring Health Services Reports 44% Jump in Adjusted EBITDA, Raises 2026 Guidance
The Louisville-based home and community-based health services provider posted second-quarter net revenue of $3.87 billion and refinanced debt following divestiture of its Community Living business.
Strong Quarter Drives Guidance Increase
BrightSpring Health Services, Inc. reported second-quarter financial results that exceeded prior-year performance across key metrics, prompting the company to raise its full-year 2026 revenue and adjusted EBITDA guidance.
The Louisville-based provider of home and community-based health services posted net revenue of $3,873 million for the quarter ended June 30, 2026, representing a 23.0% increase from $3,148 million in the year-ago period (8-K filing, 2026-07-31). All reported figures reflect continuing operations following the company's March 30, 2026 divestiture of its Community Living business.
Adjusted EBITDA reached $206 million, up 44.2% compared to $143 million in the second quarter of 2025 (8-K filing, 2026-07-31). Net income improved substantially to $87 million from $9 million in the prior-year quarter.
"We are pleased with the Company's second quarter results that reflect our quality focus, service level performance, and dedication to the patients we serve," said Jon Rousseau, Chairman, President, and Chief Executive Officer, in the filing.
Balance Sheet Improvements
BrightSpring reported leverage of 2.15x as of June 30, 2026, down from 2.27x on March 31, 2026 (8-K filing, 2026-07-31). The company executed a $300.0 million paydown and concurrent modification of its First Lien Facility during the quarter, including interest rate refinancings that resulted in interest savings.
The company also completed an underwritten secondary offering of common stock by affiliates of Kohlberg Kravis Roberts & Co. L.P. and certain members of management in June 2026, alongside a concurrent $60.0 million repurchase of 1,026,465 shares from the underwriter (8-K filing, 2026-07-31).
MarginX data shows recent insider activity including tax withholdings by CEO Jon Rousseau of 56,319 shares and CFO Scott Greenwell of 2,487 shares.
Raised Full-Year Outlook
For full-year 2026, BrightSpring increased its revenue guidance to a range of $15,100 million to $15,425 million, representing growth of 17.0% to 19.5% compared to 2025 results excluding the divested Community Living business (8-K filing, 2026-07-31).
The company expects Pharmacy Segment revenue of $13,200 million to $13,500 million, representing 15.3% to 17.9% growth, while Provider Segment revenue is projected at $1,900 million to $1,925 million, or 29.7% to 31.4% growth (8-K filing, 2026-07-31).
Total adjusted EBITDA guidance was raised to $820 million to $845 million, representing 32.8% to 36.8% growth year-over-year. The company noted that its acquisition of Amedisys and LHC branches is expected to contribute approximately $35 million in adjusted EBITDA in 2026 (8-K filing, 2026-07-31).
Business Profile
BrightSpring provides pharmacy, home health care, and rehabilitation services across all 50 states to over 485,000 customers, clients, and patients daily (8-K filing, 2026-07-31). The company, which carries a market capitalization of approximately $13 billion, closed at $60.0597 per share in its most recent trading session.
The filing included standard forward-looking statement disclosures noting risks including competitive pressures, regulatory changes, reimbursement rate fluctuations, personnel recruitment challenges, and potential cybersecurity threats.
This article was generated by MarginX from the 8-K filing on 2026-07-31. It is not investment advice.